News Updates
Clinical Application of Mesenchymal Stem Cells in Orthopaedics and Traumatology in Daily Practice
Mesenchymal stem cells (MSCs) have been widely used in preclinical and clinical orthopaedic and traumatology studies (1). Compared to other cell therapies, MSCs have a variety of characteristics, such as a lower risk of teratoma than pluripotent stem cells, stemness potency, targeted therapy through chemo-attraction, ease of isolation, and rapid proliferation (2). However, the application from bench to bedside requires a standardized procedure for its administration (1).
Source: ScienceDirect
Current and Emerging Therapies for Knee Osteoarthritis: From Conventional Approaches to Machine Learning and Stem Cell Innovations
Osteoarthritis is characterized by cartilage degradation and joint distortion. The most prevalent version of osteoarthritis, knee osteoarthritis (KOA), affects millions, acting as a leading cause of disability.
Source: ScienceDirect
Stem Cell-laden 3D Bioprinting for Osteoarthritis: Orchestrating Chondrogenic Induction and Inflammatory Microenvironment Modulation
Osteoarthritis (OA) involves irreversible cartilage degeneration and requires regenerative strategies due to limited self-repair. This review highlights the potential of stem cell-laden 3D bioprinting to engineer biomimetic cartilage scaffolds with precise control. It analyzes bioprinting methods, bioinks, and cell induction strategies, focusing on the synergistic roles of small molecules, growth factors, and exosomes in guiding stem cell differentiation.
Source: ScienceDirect
Expert Opinion on Allogeneic Bone Marrow-Derived Mesenchymal Stem Cell (BMMSC) Therapy for Knee Osteoarthritis: Clinical Insights, Efficacy, and Safety
Knee osteoarthritis (KOA) remains a major cause of disability. Many patients with moderate disease (Kellgren-Lawrence (KL) grade 2-3) continue to experience disease progression, despite receiving guideline-based conservative treatments that primarily offer symptomatic relief. Allogeneic bone marrow-derived mesenchymal stem cells (BMMSCs) have gained attention for their potential anti-inflammatory, immunomodulatory, and chondroprotective effects.
Source: Cureus
Research Landscape of Stem Cell Applications in Musculoskeletal Tissue: A Scoping Review
Stem cell therapy represents an intrinsic part of regenerative medicine, with expanding applications in orthopedic and musculoskeletal research. Although studies span from small-animal models to early-phase clinical trials, the field remains fragmented, with wide variation in stem cell types, delivery methods, and target tissues.
Source: MDPI
Comparative Efficacy of Different Doses of Mesenchymal Stem Cells Derived from Different Tissue Sources for Knee Osteoarthritis: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials
Knee osteoarthritis (KOA) remains a leading cause of disability, and mesenchymal stem cells (MSCs) show potential for KOA treatment. However, existing studies demonstrate conflicting results on the optimal dose and tissue source of MSCs for KOA treatment. This gap limits evidence-based treatment decisions.
Source: PubMed Central
Chondrogenesis of Peripheral Blood-Derived Mesenchymal Stromal Cells
Articular cartilage, a highly specialised and avascular tissue, exhibits limited regenerative potential following trauma or degenerative conditions such as osteoarthritis (OA). Conventional surgical interventions, including microfracture and autologous chondrocyte implantation (ACI), have shown limited long-term efficacy due to donor site morbidity and restricted cell proliferation. In this context, mesenchymal stromal cells (MSCs) have emerged as a promising alternative owing to their multipotency, self-renewal capacity, and low immunogenicity. While bone marrow (BM) remains the traditional source of MSCs, recent studies have reported that peripheral blood-derived mesenchymal stromal cells (PB-MSCs) may possess chondrogenic, osteogenic, and adipogenic potential comparable to that of BM-derived MSCs.
Source: PubMed
